American Century Companies’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.79M Buy
6,411
+219
+4% +$63.1K ﹤0.01% 2159
2025
Q4
$1.88M Buy
6,192
+543
+10% +$169K ﹤0.01% 2110
2025
Q3
$1.58M Buy
5,649
+172
+3% +$46.8K ﹤0.01% 2156
2025
Q2
$1.32M Buy
5,477
+114
+2% +$26.9K ﹤0.01% 2177
2025
Q1
$1.31M Sell
5,363
-236
-4% -$71K ﹤0.01% 2149
2024
Q4
$1.84M Buy
5,599
+315
+6% +$107K ﹤0.01% 2026
2024
Q3
$1.77M Sell
5,284
-96
-2% -$30.5K ﹤0.01% 2005
2024
Q2
$1.47M Buy
5,380
+240
+5% +$69.8K ﹤0.01% 2016
2024
Q1
$1.78M Sell
5,140
-357
-6% -$117K ﹤0.01% 1928
2023
Q4
$1.77M Buy
5,497
+1,646
+43% +$516K ﹤0.01% 1837
2023
Q3
$1.38M Sell
3,851
-26,585
-87% -$10.3M ﹤0.01% 1865
2023
Q2
$11.5M Sell
30,436
-16,575
-35% -$6.75M 0.01% 993
2023
Q1
$22.5M Buy
47,011
+34,008
+262% +$15.9M 0.02% 697
2022
Q4
$5.47M Buy
13,003
+10,620
+446% +$4.29M ﹤0.01% 1193
2022
Q3
$994K Buy
2,383
+859
+56% +$428K ﹤0.01% 1693
2022
Q2
$754K Buy
1,524
+238
+19% +$124K ﹤0.01% 1756
2022
Q1
$724K Buy
1,286
+158
+14% +$95.2K ﹤0.01% 1801
2021
Q4
$852K Buy
1,128
+289
+34% +$216K ﹤0.01% 1725
2021
Q3
$626K Buy
839
+95
+13% +$71.2K ﹤0.01% 1794
2021
Q2
$479K Sell
744
-404,837
-100% -$246M ﹤0.01% 1857
2021
Q1
$232M Sell
405,581
-257
-0.1% -$152K 0.17% 142
2020
Q4
$237M Sell
405,838
-179,979
-31% -$102M 0.18% 138
2020
Q3
$302M Sell
585,817
-78,043
-12% -$39.5M 0.27% 97
2020
Q2
$300M Buy
663,860
+22,742
+4% +$10M 0.28% 96
2020
Q1
$225M Sell
641,118
-77,535
-11% -$28.5M 0.27% 104
2019
Q4
$266M Sell
718,653
-8,889
-1% -$3.13M 0.25% 114
2019
Q3
$242M Sell
727,542
-21,260
-3% -$6.94M 0.24% 119
2019
Q2
$234M Sell
748,802
-40,153
-5% -$12M 0.23% 121
2019
Q1
$241M Buy
788,955
+100,850
+15% +$27.2M 0.24% 116
2018
Q4
$160M Buy
688,105
+546
+0.1% +$146K 0.18% 161
2018
Q3
$215M Sell
687,559
-4,098
-0.6% -$1.27M 0.21% 137
2018
Q2
$200M Sell
691,657
-10,709
-2% -$2.96M 0.2% 149
2018
Q1
$176M Buy
702,366
+108,949
+18% +$27.7M 0.18% 174
2017
Q4
$142M Buy
593,417
+27,220
+5% +$6.6M 0.14% 207
2017
Q3
$126M Buy
+566,197
New +$127M 0.13% 224
2016
Q2
Sell
-25,283
Closed -$3.46M 1331
2016
Q1
$3.46M Sell
25,283
-22,462
-47% -$2.95M ﹤0.01% 902
2015
Q4
$6.62M Sell
47,745
-55,587
-54% -$7.7M 0.01% 744
2015
Q3
$13.9M Sell
103,332
-24,292
-19% -$3.5M 0.02% 577
2015
Q2
$19.2M Sell
127,624
-340,548
-73% -$48.7M 0.02% 563
2015
Q1
$63.3M Buy
468,172
+81,929
+21% +$10.2M 0.07% 349
2014
Q4
$46.6M Buy
386,243
+23,979
+7% +$2.76M 0.05% 398
2014
Q3
$41.1M Buy
362,264
+14,216
+4% +$1.68M 0.05% 399
2014
Q2
$41.7M Buy
348,048
+35,181
+11% +$4.3M 0.05% 398
2014
Q1
$40.1M Buy
312,867
+13,197
+4% +$1.69M 0.05% 408
2013
Q4
$37M Buy
299,670
+49,020
+20% +$5.97M 0.04% 413
2013
Q3
$29.5M Buy
+250,650
New +$29.6M 0.04% 441

Other funds holding BIO